Thales Prepares to Secure European Infrastructures Against Attacks From Future Quantum Computers
14.4.2023 15:03:00 EEST | Business Wire | Press release
As a driving force in the second quantum revolution, Thales has joined forces with around twenty deep tech, academic and industry partners, as part of the EuroQCI initiative (European Quantum Communication Infrastructure), which aims to deploy a quantum communication infrastructure for EU member states within three years.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230414005211/en/
©Carlos Castilla
By 2040, quantum computers could use their unprecedented computational power to decode encrypted data, incomparably threatening the security of even the best-protected communication systems. EuroQCI aims to counter that threat by developing sovereign systems to protect the communications and data assets of critical infrastructure providers and government institutions.
The longer-term objective of the initiative is to create a Quantum Information Network (QIN) that will harness the phenomenon of quantum entanglement not only to guarantee communications security but also to create networks of quantum sensors and processors, which have the potential to drive exponential increases in the already outstanding performance of quantum sensors and quantum computers.
As part of this effort, today, Thales is breaking new ground as a member of multiple new consortia that have been set up since late 2022 in these domains:
- Quantum repeaters, with the Delft University: QIA (Quantum Internet Alliance) – led by the Delft University of Technology in the Netherlands – is working to demonstrate the feasibility of connecting users in two metropolitan areas 500 km apart, using quantum repeaters, which can compensate for the loss of information via a quantum memory;
- Quantum key distribution: QKISS – coordinated by Exail – and QUARTER – led by LuxQuanta – are developing Quantum Key Distribution systems to protect users' critical communications from cyberattacks.
- Certification of quantum communication: PETRUS – led by Deutsche Telekom – is the official coordinator of 32 EuroQCI projects, on behalf of the European Commission. It is also developing a framework for certification and accreditation of quantum communication products and networks.
- Satellites quantum communications: TeQuantS – led by Thales Alenia Space – aims at developing quantum space-to-Earth communications technologies, necessary for cybersecurity applications and future quantum information networks, through the construction of satellites and optical ground stations by the end of 2026.
Specifically, the Thales teams taking part in these projects are working to develop quantum key generation, distribution and management equipment and the associated communication encryption devices, as well as defining the architecture of these quantum communication infrastructures.
Thales operates the largest quantum physics research facilities in Europe, in partnership with the CNRS, and some 100 engineers and researchers are currently engaged in the development of the quantum solutions (sensors, communications and algorithms) that will play a foundational role in tomorrow's world. These new consortia will all benefit from Thales's multi-disciplinary expertise, in particular in the field of secure communication networks.
Thales (Euronext Paris: HO) is a global leader in advanced technologies within three domains: Defence & Security, Aeronautics & Space, and Digital Identity & Security. It develops products and solutions that help make the world safer, greener and more inclusive.
The Group invests close to €4 billion a year in Research & Development, particularly in key areas such as quantum technologies, Edge computing, 6G and cybersecurity.
Thales has 77,000 employees in 68 countries. In 2022, the Group generated sales of €17.6 billion.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230414005211/en/
Contact information
PRESS
Thales, Media Relations
Philomène Emptaz
philomene.emptaz@thalesgroup.com
06. 59. 06. 98. 76
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
VerSprite Launches Fork and Knife: AI-Driven Threat Modeling and Adversarial Testing Built for the Speed of Modern Software27.6.2026 00:28:00 EEST | Press release
VerSprite, a global leader in risk-based threat modeling and the firm behind the PASTA (Process for Attack Simulation and Threat Analysis) methodology, today announced the general availability of Fork (www.forktm.com), a continuous application threat modeling platform, alongside Knife, an AI-led, human-on-the-loop adversarial testing platform for web applications and web API endpoints. Together, the two products operationalize a new model for product security—one where applications are securely designed, continuously modeled, and actively tested as part of the build process itself. The launch addresses a problem every security leader knows but few tools have solved: threat modeling is essential, never more so than in an AI-driven era, yet it has remained slow, manual, and anchored to frameworks designed for a different threat landscape. The problem: threat modeling matters more than ever—and most tools are stuck in 2005 For two decades, application threat modeling has leaned heavily on
Venture Global Announces Closing of $1.5 Billion Senior Secured Vessel Financing Facility26.6.2026 23:30:00 EEST | Press release
Venture Global, Inc. (NYSE: VG) announced today that its wholly-owned subsidiary, Venture Global Shipping Holdings, LLC (“VGSH”), has entered into a Credit and Guaranty Agreement providing for a senior secured term loan facility (the “Facility”) in an aggregate principal amount of up to $1,500,000,000. The Facility will mature on June 26, 2032. Deutsche Bank and ING acted as coordinating lead arrangers for the Facility. ING also serves as facility agent and security trustee. VGSH intends to use the net proceeds from the Facility for general corporate purposes, including to reimburse Venture Global LNG, Inc. for payments previously made by it or its affiliates in connection with the acquisition of nine LNG carriers, funding certain reserve accounts, and paying transaction fees and expenses. About Venture Global Venture Global is an American producer and exporter of low-cost U.S. liquefied natural gas (“LNG”) with over 100 MTPA of capacity in production, construction, or development. Ven
Capco Recognized by OpenAI for Innovation and Responsible AI Leadership26.6.2026 21:00:00 EEST | Press release
Global management and technology consultancy Capco, a Wipro company,has been recognized by OpenAI for both AI innovation and responsible AI leadership. Capco received the AI Governance & Risk Excellence Award at the recent OpenAI Partner Summit 2026 in San Francisco, highlighting Capco’s ability to deliver enterprise-grade AI outcomes in highly regulated environments. The award recognizes Capco’s expert advantage when helping financial services and energy organizations to scale AI with confidence, balancing innovation with strong governance to reduce risk, strengthen compliance and improve customer outcomes. This award follows Capco winning the OpenAI Codex Hackathon, where its UK AI Lab competed against more than 30 teams and over 100 participants from across the OpenAI partner ecosystem. Capco's winning entry Sentra – a consulting-led, AI-powered retail banking solution – uses digital twin technology to identify vulnerable customers and recommend explainable next-best actions for fro
Incyte Announces Positive CHMP Opinion for Opzelura ® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 14:30:00 EEST | Press release
Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate. “AD is a chronic skin condition that can have a significant impact on daily life. The positive CHMP opinion for Opzelura marks meaningful progress toward bringing the first non-steroidal topical JAK treatment option to adults in Europe with moderate AD for whom standard topical therapies have failed,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved by the European Commission, Opzelura could help address an important gap for patients who have limited treatment options when TCSs and TCIs are inadequate or inappropriate.” The positive CHMP o
Datroway ® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 14:00:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast02phase 3 trial, which werepresented at the 2025 European Society for Medical Oncology Congress and published in Annals of Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast02, Datroway demonstrated a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom